Inhibrx Biosciences, Inc. INBX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s total equity?
- Inhibrx Biosciences, Inc. (INBX) reported total equity of -$21.04M in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s total equity changed year-over-year?
- Inhibrx Biosciences, Inc.'s total equity decreased by 122.3% year-over-year, from $94.44M to -$21.04M.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s total equity?
- Over 3 years (2022 to 2025), Inhibrx Biosciences, Inc.'s total equity has grown at a -48.4% compound annual growth rate (CAGR), from $58.06M to $7.99M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.